{"100-1.\n\u4e00\u4f4d30\u6b72\u7537\u6027\u8d74\u6771\u5357\u4e9e\u65c5\u904a\uff0c\u56de\u570b\u5f8c\u56db\u500b\u6708\u51fa\u73fe\u5982\u5716\u4e4b\u76ae\u75b9\uff0c\u4e0b?\u4f55\u8005\u70ba\u6700\u53ef\u80fd\u7684\u8a3a\u65b7\uff1f\nA. \u6885\u6bd2 (syphilis)\nB. \u767b\u9769\u71b1(dengue fever)\nC. \u6dcb\u75c5(gonorrhea)\nD. \u624b\u53e3\u8db3\u75c7(hand-foot-mouth disease)\nE. \u73ab\u7470\u7ce0\u75b9(pityriasis rosea)\n": "(A)", "100-2.\n\u6709\u95dc\u5982\u5716\u6240\u793a\u5287\u7662\u3001\u53cd\u8986\u767c\u751f\u4e4b\u76ae\u819a\u75c5\uff0c\u4ee5\u4e0b\u6558\u8ff0\u4f55\u8005\u4e0d\u6b63\u78ba\uff1f\nA. \u8207\u5bb6\u65cf\u907a\u50b3\u6709\u95dc\nB. \u8840\u6db2\u4e2dIgE\u5e38\u9ad8\u65bc\u6b63\u5e38\u4eba\nC. \u5728\u53f0\u7063\u5e38\u898b\u5c0d\u5875\u9862\u904e\u654f\nD. \u5c45\u4f4f\u74b0\u5883\u8d8a\u4e7e\u71e5\u8d8a\u597d\nE. \u53ef\u7528\u985e\u56fa\u9187\u85e5\u818f\u6cbb\u7642\n": "(D)", "100-3.\n\u5982\u5716\u6240\u793a\u4e4b\u76ae\u819a\u816b\u7624\u662f\uff1f\nA. \u68d8\u7d30\u80de\u764c (squamous cell carcinoma)\nB. \u57fa\u5e95\u7d30\u80de\u764c (basal cell carcinoma)\nC. \u6ce2\u6587\u6c0f\u75c7 (Bowen's disease)\nD. \u60e1\u6027\u9ed1\u7d20\u7624 (malignant melanoma)\nE. \u8840\u7ba1\u8089\u7624 (angiosarcoma)\n": "(B)", "100-4.\n\u4ee5\u4e0b\u6709\u95dc\u5982\u5716\u6240\u793a\u76ae\u819a\u75c5\u4e4b\u6558\u8ff0\uff0c\u4f55\u8005\u4e0d\u6b63\u78ba\uff1f\nA. \u6709Auspitz sign\u548cKoebner phenomenon\nB. \u53e3\u670d\u76ae\u8cea\u985e\u56fa\u9187\u53ef\u5f97\u5f88\u597d\u7684\u6548\u679c\uff0c\u662f\u6cbb\u7642\u7684\u9996\u9078\nC. \u92f0\u9e7d\u3001\u6297\u7627\u5291\u3001\u9152\u7cbe\u53ca\u4e59\u578b\u963b\u65b7\u5291\u7684\u6295\u4e88\u6703\u52a0\u91cd\u75c5\u60c5\nD. \u5354\u52a9\u8005T\u7d30\u80de\u5341\u4e03\u578b(Th17) \u8207 T\u7d30\u80de\u4e00\u578b\uff08Th1\uff09\u4e4b\u6d3b\u5316\u88ab\u8a8d\u70ba\u662f\u5f15\u767c\u4e7e\u766c\u7684\u91cd\u8981\u6a5f\u8f49\nE. \u53ef\u7167\u5c04\u7a84\u6ce2\u7d2b\u5916B\u5149(311nm)\u4f86\u6cbb\u7642\n": "(B)", "100-5.\n\u6709\u95dc\u809d\u6591 (chloasma, melasma)\uff0c\u4e0b\u5217\u6558\u8ff0\u4f55\u8005\u70ba\u975e\uff1f\nA. \u4e3b\u8981\u767c\u751f\u65bc\u984f\u9762\u7684\u5c0d\u7a31\u6027\u8272\u7d20\u6591\nB. \u809d\u529f\u80fd\u7570\u5e38\u8005\u5e38\u898b\nC. \u53e3\u670d\u907f\u5b55\u85e5\u70ba\u53ef\u80fd\u75c5\u56e0\u4e4b\u4e00\nD. \u60a3\u8005\u61c9\u907f\u514d\u967d\u5149\u7167\u5c04\nE. \u7528\u7d05\u5bf6\u77f3\u96f7\u5c04(Ruby laser)\u6cbb\u7642\u53cd\u800c\u6703\u60e1\u5316\u75c5\u60c5\n": "(B)", "100-6.\n\u4e00\u4f4d40\u6b72\u5973\u6027\uff0c\u8fd1\u534a\u5e74\u4f86\u5728\u81c9\u90e8\u3001\u9838\u90e8\u8207\u524d\u80f8\u90e8\u76ae\u819a\uff0c\u51fa\u73fe\u5982\u5716\u4e4b\u8868\u73fe\u3002\u95dc\u65bc\u8a72\u60a3\u8005\u8a3a\u65b7\u8207\u6cbb\u7642\u7684\u63cf\u8ff0\uff0c\u4f55\u8005\u6b63\u78ba\uff1f(\u61c9\u9078\u51fa\u5168\u90e8\u7b54\u6848)\r1.\u76ae\u819a\u75c5\u7406\u6709\u660e\u986f\u767c\u708e\u53cd\u61c9\uff0c\u9020\u6210\u8272\u7d20\u812b\u5931\r2.\u76ae\u819a\u9ed1\u8272\u7d20\u7d30\u80de\u6578\u76ee\u6e1b\u5c11\r3.\u61c9\u505a\u7532\u72c0\u817a\u529f\u80fd\u8207\u6297\u9ad4\u7684\u6aa2\u67e5\r4.UVB1\uff08311nm\uff09\u7a84\u6ce2\u7d2b\u5916\u5149\u53ef\u4fc3\u9032\u8272\u7d20\u56de\u5fa9\nA. 1+3\nB. 2+4\nC. 1+2+3\nD. 2+3+4\nE. 1+2+3+4\n": "(D)", "100-7.\n\u4e0b\u5217\u95dc\u65bc\u8541\u9ebb\u75b9(urticaria)\u4e4b\u6558\u8ff0\uff0c\u4f55\u8005\u70ba\u662f\uff1f(\u61c9\u9078\u51fa\u5168\u90e8\u7b54\u6848)\r1.\u8541\u9ebb\u75b9\u4e4b\u55ae\u4e00\u75c5\u7076\u5e38\u6301\u7e8c24 \u5c0f\u6642\u4ee5\u4e0a\r2.\u4e5f\u662f\u904e\u654f\u6027\u4f11\u514b(anaphylaxis)\u7684\u76ae\u819a\u8868\u73fe\r3.\u4e00\u5b9a\u662f\u85e5\u7269\u904e\u654f\u6240\u5f15\u8d77\r4.\u4f75\u7528aspirin\uff0c\u53ef\u80fd\u6703\u4f7f\u6b64\u75c5\u60e1\u5316\nA. 1+3\nB. 2+4\nC. 1+2+3\nD. 2+3+4\nE. 1+2+3+4\n": "(B)", "101-1.\n\u4e00\u4f4d30\u6b72\u7537\u6027\u8d74\u6771\u5357\u4e9e\u65c5\u904a\uff0c\u56de\u570b\u5f8c\u56db\u500b\u6708\u51fa\u73fe\u624b\u638c\u8173\u638c\u76ae\u75b9\uff0c\u540c\u6642\uff0c\u5168\u8eab\u4e5f\u6709\u7d05\u75b9(\u5982\u5716\u6240\u793a\uff09\u3002\u4ee5\u4e0b\u4f55\u8005\u70ba\u6700\u53ef\u80fd\u7684\u8a3a\u65b7\uff1f\nA. \u5fc3\u5167\u819c\u708e(endocarditis)\nB. \u767b\u9769\u71b1(dengue fever)\nC. \u6dcb\u75c5(gonorrhea)\nD. \u6885\u6bd2 (syphilis)\nE. \u611b\u6ecb\u75c5\uff08AIDS\uff09\n": "(D)", "101-2.\n\u4e00\u4f4d65 \u6b72\u5973\u6027\uff0c\u8eab\u6750\u80a5\u80d6\uff0c\u7f79\u60a3\u7cd6\u5c3f\u75c510\u5e74\uff0c\u4f46\u4e0d\u898f\u5247\u5c31\u91ab\u670d\u85e5\uff0c\u4e00\u661f\u671f\u524d\u5728\u4e73\u623f\u4e0b\u51fa\u73fe\u523a\u7662\u7684\u7d05\u8272\u6591(\u5982\u5716\u6240\u793a)\uff0c\u4e0b\u5217\u4f55\u8005\u70ba\u6700\u53ef\u80fd\u7684\u8a3a\u65b7\uff1f\nA. \u81bf\u75c2\u75b9\uff08impetigo\uff09\nB. \u55ae\u7d14\u6027\u76b0\u75b9\u75c5\u6bd2\u611f\u67d3\uff08herpes simplex virus infection\uff09\nC. \u76ae\u819a\u5ff5\u73e0\u83cc\u611f\u67d3\uff08cutaneous candidiasis\uff09\nD. \u6bdb\u56ca\u708e\uff08folliculitis\uff09\nE. \u9ad4\u766c (tinea corporis)\n": "(C)", "101-3.\n\u4e0b\u5217\u95dc\u65bc\u8541\u9ebb\u75b9(urticaria)\u4e4b\u6558\u8ff0\uff0c\u4f55\u8005\u70ba\u975e\uff1f\nA. \u5e38\u7528\u6297\u7d44\u7e54\u80fa\u85e5\u7269\u6cbb\u7642\nB. \u6240\u6709\u7684\u75c5\u4eba\u7686\u53ef\u627e\u51fa\u539f\u56e0\nC. \u4f75\u7528aspirin\uff0c\u5e38\u4f7f\u6b64\u75c5\u60e1\u5316\nD. \u8541\u9ebb\u75b9\u4e4b\u55ae\u4e00\u75c5\u7076\u5e38\u572824 \u5c0f\u6642\u5167\u6d88\u5931\nE. \u61c9\u5148\u8a62\u554f\u75c5\u4eba\u7684\u7528\u85e5\u53f2\n": "(B)", "101-4.\n\u5982\u5716\u6240\u793a\u7684\u591a\u767c\u6027\u76ae\u75b9\uff0c \u4ee5\u4e0b\u7684\u6558\u8ff0\u4f55\u8005\u6b63\u78ba\uff1f\nA. \u5b83\u6e90\u65bc\u7e96\u7dad\u82bd\u7d30\u80de(fibroblast)\nB. \u597d\u767c\u65bc\u4e0b\u80a2\nC. \u5e38\u898b\u65bc\u9752\u5e74\u4eba\nD. \u77ed\u671f\u5167\u5168\u8eab\u51fa\u73fe\u5f88\u591a\u6642\uff0c\u61c9\u61f7\u7591\u662f\u5426\u5408\u4f75\u5167\u81df\u764c\nE. \u5f88\u5bb9\u6613\u8f49\u8b8a\u6210\u57fa\u5e95\u7d30\u80de\u764c\n": "(D)", "101-5.\n\u5982\u5716\u6240\u793a\u7684\u591a\u767c\u6027\u76ae\u75b9\uff0c \u4ee5\u4e0b\u7684\u6558\u8ff0\u4f55\u8005\u70ba\u932f\u8aa4\uff1f\nA. \u6709Auspitz sign\u548cKoebner phenomenon\nB. \u92f0\u9e7d\u3001\u6297\u7627\u5291\u3001\u9152\u7cbe\u53ca\u4e59\u578b\u963b\u65b7\u5291\u6703\u52a0\u91cd\u75c5\u60c5\nC. \u5354\u52a9\u8005T\u7d30\u80de\u4e00\u578b\uff08Th1\uff09\u8207T\u7d30\u80de\u5341\u4e03\u578b(Th17)\u514d\u75ab\u53cd\u61c9\u88ab\u8a8d\u70ba\u662f\u5f15\u767c\u6b64\u75c5\u7684\u91cd\u8981\u6a5f\u8f49\nD. \u53e3\u670d\u76ae\u8cea\u985e\u56fa\u9187\u53ef\u5f97\u5f88\u597d\u7684\u6548\u679c\uff0c\u662f\u6cbb\u7642\u7684\u9996\u9078\nE. \u75c5\u60a3\u6709\u8f03\u9ad8\u6bd4\u4f8b\u4f75\u6709metabolic syndrome\n": "(D)", "101-6.\n\u6709\u95dc\u5982\u5716\u6240\u793a\u76ae\u819a\u8272\u7d20\u6591\uff0c\u4ee5\u4e0b\u7684\u6558\u8ff0\uff0c\u4f55\u8005\u932f\u8aa4\uff1f\nA. \u662f\u8868\u76ae\u5c64\u7684\u9ed1\u8272\u7d20\u589e\u52a0\u9020\u6210\nB. \u809d\u529f\u80fd\u7570\u5e38\u8005\u5e38\u898b\nC. \u53e3\u670d\u907f\u5b55\u85e5\u70ba\u53ef\u80fd\u75c5\u56e0\u4e4b\u4e00\nD. \u60a3\u8005\u61c9\u907f\u514d\u967d\u5149\u7167\u5c04\nE. \u96f7\u5c04\u6703\u4f7f\u4e4b\u60e1\u5316\n": "(B)", "101-7.\n\u4e0b\u5217\u4f55\u8005\u4e0d\u662f\u611b\u6ecb\u75c5\u4e4b\u5e38\u898b\u76ae\u819a\u75c5\u8b8a\uff1f\nA. \u5361\u6ce2\u897f\u6c0f\u8089\u7624\uff08Kaposi's sarcoma\uff09\nB. \u6cdb\u767c\u6027\u8edf\u75a3\uff08disseminated molluscum contagiosum\uff09\nC. \u65e5\u5149\u654f\u611f\u6027\u76ae\u819a\u708e\uff08photosensitive dermatitis\uff09\nD. \u53e3\u8154\u6bdb\u72c0\u9ecf\u819c\u767d\u6591\uff08oral hairy leukoplakia\uff09\nE. \u809b\u9580\u5468\u570d\u5c16\u75a3 \uff08perianal condyloma acuminatum\uff09\n": "(C)", "102-1.\n\u4e00\u4f4d30\u6b72\u7537\u6027\u8d74\u6771\u5357\u4e9e\u65c5\u904a\uff0c\u56de\u570b\u5f8c\u56db\u500b\u6708\u51fa\u73fe\u624b\u638c\u8173\u638c\u76ae\u75b9\uff0c\u540c\u6642\uff0c\u5168\u8eab\u4e5f\u6709\u7d05\u75b9(\u5982\u5716\u793a),\u4ee5\u4e0b\u4f55\u8005\u662f\u5fc5\u8981\u8655\u7f6e? (1)\u8a62\u554f\u7528\u85e5\u53f2 (2)\u8a62\u554f\u6027\u884c\u70ba\u53f2 (3)\u6aa2\u6e2cTPHA\uff0cVDR\u6216RPR (4)\u6aa2\u6e2crubella IgM (5)\u6aa2\u6e2c\u809d\u529f\u80fd\nA. (1)+(3)+(5)\nB. (1)+(4)+(5)\nC. (1)+(2)+(3)\nD. (2)+(3)+(4)\nE. (2)+(3)+(5)\n": "(C)", "102-2.\n\u4e00\u4f4d40\u6b72\u5973\u6027\uff0c\u8fd1\u534a\u5e74\u4f86\u5728\u81c9\u90e8\u3001\u9838\u90e8\u8207\u524d\u80f8\u90e8\u76ae\u819a\uff0c\u51fa\u73fe\u5982\u5716\u4e4b\u8868\u73fe\u3002\u95dc\u65bc\u8a72\u75be\u75c5\u7684\u63cf\u8ff0\uff0c\u4f55\u8005\u6b63\u78ba\uff1f(1) \u8868\u76ae\u9ed1\u8272\u7d20\u7d30\u80de\u6578\u76ee\u6e1b\u5c11\u6216\u6d88\u5931 (2)\u6bdb\u56ca\u9ed1\u8272\u7d20\u7d30\u80de\u6578\u76ee\u6b63\u5e38 (3)\u61c9\u505a\u7532\u72c0\u817a\u529f\u80fd\u8207\u6297\u9ad4\u7684\u6aa2\u67e5 (4)UVB1\uff08311nm\uff09\u7a84\u6ce2\u7d2b\u5916\u5149\u53ef\u4fc3\u9032\u8272\u7d20\u56de\u5fa9 (5)\u76ae\u819a\u75c5\u7406\u6709\u660e\u986f\u767c\u708e\u53cd\u61c9\uff0c\u9020\u6210\u8272\u7d20\u812b\u5931\nA. (1)+(2)+(3)+(5)\nB. (1)+(3)+(4)+(5)\nC. (1)+(2)+(4)+(5)\nD. (1)+(2)+(3)+(4)\nE. (2)+(3)+(4)+(5)\n": "(D)", "102-3.\n\u6b64\u4e0055\u6b72\u7537\u6027\uff0c\u5728\u81c9\u4e0a\u53ca\u4e0a\u8ec0\u5e79\u767c\u751f\u591a\u767c\u6027\u5982\u5716\u793a\u4e4b\u7d05\u75b9\uff0c\u9996\u5148\u8981\u8003\u616e\u4ed6\u6709\u4ee5\u4e0b\u4f55\u7a2e\u75be\u75c5\uff1f\nA. Liver cirrhosis\nB. Erythema multiforma\nC. Photosensitive dermatitis\nD. Systemic lupus erythematosus\nE. Rosacea\n": "(A)", "102-4.\n\u5982\u5716\u793a\u4e4b\u4e0d\u7662\u3001\u4e0d\u75db\u3001\u7121\u9e9f\u5c51\u76ae\u75b9\u767c\u751f\u65bc\u81c9\u4e0a\u5df2\u67092\u500b\u6708\uff0c\u8a3a\u65b7\u662f\uff1f\nA. Systemic lupus erythematosus\nB. Contact dermatitis\nC. Rosacea\nD. Sun burn\nE. Seborrheic dermatitis\n": "(A)", "102-5.\n\u6b64\u75c5\u60a3\u53cd\u8986\u767c\u751f\u5982\u5716\u793a\u76ae\u75b9\u5df2\u67093\u500b\u6708\uff0c\u4e0b\u5217\u6558\u8ff0\u4f55\u8005\u932f\u8aa4\uff1f\nA. \u61c9\u8a62\u554f\u662f\u5426\u6b63\u4f7f\u7528NSAID (nonsteroidal antinflammatory drug)\nB. \u61c9\u8a62\u554f\u662f\u5426\u6b63\u4f7f\u7528angiotensin- converting enzyme inhibitors\nC. \u61c9\u8a62\u554f\u500b\u5225\u7684\u76ae\u75b9\u662f\u4e0d\u662f24\u5c0f\u6642\u5167\u6703\u6d88\u5931\nD. \u61c9\u8a62\u554f\u662f\u5426\u6709\u4f34\u96a8\u7684\u75c7\u72c0\nE. \u53ea\u6709\u505aantigen specific IgE \u6aa2\u6e2c\uff0c\u624d\u80fd\u627e\u51fa\u771f\u6b63\u7684\u539f\u56e0\n": "(E)", "102-6.\n\u5982\u5716\u793a\u76ae\u75b9\uff0c\u4f75\u6709\u795e\u7d93\u75db\uff0c\u4e0b\u5217\u6558\u8ff0\u4f55\u8005\u932f\u8aa4\uff1f\nA. \u8a3a\u65b7\u662fherpes zoster\nB. \u767c\u751f\u5728cranial nerve V1 branch\nC. \u61c9\u505a\u773c\u79d1\u6aa2\u67e5\nD. \u6700\u4f73\u8655\u7f6e\u662facyclovir\u7684\u76f4\u63a5IV push\nE. 65\u6b72\u4ee5\u4e0a\u8001\u4eba\u5f8c\u907a\u7684\u795e\u7d93\u75db\u4e00\u822c\u8f03\u56b4\u91cd\u4e5f\u8f03\u6301\u4e45\n": "(D)", "102-7.\n\u4e00\u4f4d\u5be6\u7fd2\u91ab\u5e2b\u7a81\u7136\u5728\u81c9\u90e8\u53ca\u8ec0\u5e79\u767c\u751f\u5982\u5716\u793a\u7684\u76ae\u75b9\uff0c\u4f75\u6709\u767c\u71d2\uff0c\u6700\u53ef\u80fd\u7684\u8a3a\u65b7\u662f\uff1f\nA. Varicella\nB. Stevens-Johnson syndrome\nC. Rubella\nD. Sudamina\nE. Pityriasis lichenoides et varioliformis acuta\n": "(A)", "103-1.\n\u4e0024\u6b72\u7537\u6027\uff0c\u56e02 \u661f\u671f\u4ee5\u4f86fever, chills, malaise and fatigue\u81f3\u6025\u8a3a\u5c31\u91ab\u3002\u4ed6\u8fd1\u671f\u66fe\u53bb\u6cf0\u570b\u65c5\u904a\u4e26\u5ad6\u5993\u3002 \u4ed6\u611f\u89ba\u5589\u56a8\u75db\uff0c\u53e3\u8154\u4e26\u6709painful sores; \u5168\u8eab\u53ca\u56db\u80a2\u6709 diffuse erythematous rash\u3002 \u8eab\u9ad4\u6aa2\u67e5\u767c\u73fe\uff1a\u9ad4\u6eab38.2\u00b0C, \u8840\u58d3 130/78 mmHg, \u8108\u640f99/min, \u547c\u543812/min\u3002\u5728groins \u53ca supraclavicular region \u6709non-tender lymphadenopathy\u3002\u7121\u95dc\u7bc0\u816b\u8139\u6216\u75bc\u75db\u3002\u4e0b\u4e00\u6b65\u61c9\u505a\u4ee5\u4e0b\u4f55\u7a2e\u6aa2\u67e5\uff1f(1) HIV viral load (2) Parvovirus B19 IgM antibody assay\uff1b(3) Rapid plasma reagin test (4) Heterophile antibody test  (\u61c9\u9078\u51fa\u6240\u6709\u6b63\u78ba\u7b54\u6848)\nA. (1)+(3)\nB. (2)+(4)\nC. (1)+(2)+(3)\nD. (2)+(3)+(4)\nE. (1)+(2)+(3)+(4)\n": "(A)", "103-2.\n\u4e00\u4f4d50\u6b72\u7537\u6027\uff0c\u767c\u751f\u5982\u5716\u6240\u793a\u4e4b\u5168\u8eab\u76ae\u819a\u7d05\u75b9\uff0c\u8986\u84cb\u5168\u8eab\u7d0410%\u9762\u7a4d\u3002\u53cd\u53cd\u8986\u8986\u5df2\u67092\u5e74\uff0c\u8acb\u554f\u4ee5\u4e0b\u4f55\u8005\u70ba\u9069\u7576\u8655\u7f6e\uff1f  (1) \u53e3\u670d\u985e\u56fa\u9187 (2) \u5857\u62b9\u985e\u56fa\u9187\u85e5\u818f (3) \u53e3\u670dcalcipotriol (4) \u5857\u62b9calcipotriol\u85e5\u818f (5) \u7a84\u6ce2311nm\u7d2b\u5916\u7ddaB\u7167\u5c04\u6cbb\u7642\u3002 (\u61c9\u9078\u51fa\u6240\u6709\u6b63\u78ba\u7b54\u6848)\nA. (1)+(3)+(5)\nB. (2)+(4)+(5)\nC. (1)+(2)+(3)\nD. (2)+(3)+(4)\nE. (1)+(2)+(3)+(4)+(5)\n": "(B)", "103-3.\n\u4e0058\u6b72\u7537\u6027\uff0c\u76ae\u819a\u7662\u53ca\u812b\u5c51\u5df2\u67093\u5e74\u3002\u8fd13\u500b\u6708\u4ee5\u4f86\uff0c\u7531\u6591\u584a\u8b8a\u6210\u5168\u8eab\u767c\u7d05\u3002\u76ae\u819a\u5287\u7662\u81f3\u6703\u5e72\u64fe\u751f\u6d3b\u7684\u7a0b\u5ea6\u3002\u7528\u85e5\u65b9\u9762\u53ea\u6709\u8fd15\u5e74\u4f86\u4f7f\u7528lisinpril\u63a7\u5236\u9ad8\u8840\u58d3\u3002\u8eab\u9ad4\u6aa2\u67e5\u767c\u73fevital signs\u90fd\u6b63\u5e38\u3002\u9ad4\u8868\u5982\u5716\u6240\u793a90%\u76ae\u819a\u90fd\u767c\u7d05\u4e26\u812b\u5c51\uff0c\u800c\u4e14\u6709alopecia, thickening of nails, palms and soles, generalized lymphadenopathy\u3002\u4ee5\u4e0b\u4f55\u8005\u662f\u6700\u53ef\u80fd\u7684\u8a3a\u65b7\uff1f\nA. Drug hypersensitivity reaction\nB. Pustular psoriasis\nC. Staphylococcal scalded skin syndrome\nD. Cutaneous T-cell lymphoma\nE. Atopic dermatitis\n": "(D)", "103-4.\n\u5982\u5716\u6240\u793a\u81c9\u90e8\u7684\u6162\u6027\u589e\u5927\u55ae\u4e00\u816b\u584a\uff0c\u4e0b\u5217\u4f55\u8005\u662f\u6700\u53ef\u80fd\u7684\u8a3a\u65b7\uff1f\nA. Basal cell carcinoma\nB. Melanoma\nC. Seborrheic keratosis\nD. Sebaceous carcinoma\nE. Squamous cell carcinoma\n": "(A)", "103-5.\n\u4e00\u4f4f\u5b89\u990a\u9662\u8001\u4eba\u65bc\u8eab\u4e0a\u3001\u56db\u80a2\u53ca\u751f\u6b96\u5668\u767c\u751f(\u5982\u5716A\u53ca\u5716B)\u5287\u7662\u76ae\u75b9\u5df2\u67092\u500b\u6708\uff0c\u8eab\u9ad4\u6aa2\u67e5\u767c\u73fevital signs\u90fd\u6b63\u5e38\u3002\u61c9\u4f5c\u4f55\u7a2e\u6aa2\u67e5\u4ee5\u78ba\u5b9a\u8a3a\u65b7\uff1f\nA. Complete blood count\nB. Serum tissue transglutaminase level\nC. Skin biopsy for direct immunofluorescence microscopy\nD. Microscopic evaluation of skin scraping\nE. Thyroid function test\n": "(D)", "103-6.\n\u4e0037\u6b72\u7537\u6027\u5728\u53f3\u817f\u767c\u751f\u7d05\u3001\u816b\u3001\u71b1\u3001\u75db\u5df2\u67092\u5929(\u5982\u5716A\u53ca\u5716B)\u3002\u4ed6\u6709\u9999\u6e2f\u8173\uff0c\u7121\u6162\u6027\u817f\u90e8\u6c34\u816b\u75c5\u53f2\u3002\u8eab\u9ad4\u6aa2\u67e5\u767c\u73fe\u9ad4\u6eab38.4\u00b0 C; \u5176\u4ed6vital signs\u90fd\u6b63\u5e38\u3002BMI 30 kg/m2. \u8acb\u4e0b\u5217\u4f55\u8005\u662f\u6700\u53ef\u80fd\u7684\u8a3a\u65b7\uff1f\nA. Cellulitis\nB. Contact dermatitis\nC. Insect bite reaction\nD. Stasis dermatitis\nE. Erythema nodosum\n": "(A)", "103-7.\n\u4e00\u7537\u6027\u75c5\u60a3\u5728\u80ef\u4e0b\u767c\u751f\u5982\u5716\u6240\u793a\u6703\u7662\u76ae\u75b9\uff0c\u81f3\u897f\u85e5\u623f\u8cb7\u985e\u56fa\u9187\u85e5\u818f\u4f86\u64e6\uff0c\u6bcf\u6b21\u64e6\u5f8c\u7662\u611f\u6703\u6539\u5584\uff0c\u4f46\u76ae\u75b9\u8d8a\u64f4\u8d8a\u5927\uff0c\u8acb\u554f\u4e0b\u5217\u4f55\u8005\u662f\u6700\u53ef\u80fd\u7684\u8a3a\u65b7\uff1f\nA. Atopic dermatitis\nB. Nummular eczema\nC. Psoriasis\nD. Tinea cruris\nE. Candidiasis\n": "(D)", "104-1.\n30\u6b72\u7537\u6027, \u76ae\u819a\u75c5\u8b8a\u5982\u5716, \u4ee5\u4e0b\u4f55\u8005\u70ba\u5fc5\u9700\u4e4b\u8655\u7f6e\uff1f(1) \u62bd\u8840\u6aa2\u67e5\u6709\u7121HIV\u611f\u67d3\uff1b (2) \u8a62\u554f\u6027\u884c\u70ba\u53f2\uff1b(3) \u62bd\u8840\u6aa2\u67e5\u6709\u7121\u6885\u6bd2\uff1b(4) \u5207\u53d6\u7d44\u7e54\u4f5c\u75c5\u7406\u6aa2\u67e5\nA. (1)+(3)\nB. (2)+(4)\nC. (1)+(2)+(3)\nD. (4)\nE. (1)+(2)+(3)+(4)\n": "(C)", "104-2.\n\u4e00\u4f4d50\u6b72\u5973\u6027\uff0c\u767c\u751f\u5982\u5716\u6240\u793a\u7684\u76ae\u75b9\u3002\u76ae\u819a\u5207\u7247\u6aa2\u67e5\u767c\u73fe\u6709 acantholysis, keratinocytes necrosis \u53cavacuolar-interface dermatitis\u3002\u76f4\u63a5\u514d\u75ab\u87a2\u5149\u53cd\u61c9\uff08DIF\uff09\u767c\u73feIgG\u53cacomplement\u6c88\u7a4d\u65bc\u89d2\u8cea\u7d30\u80de\u8868\u9762\u53ca\u8868\u76ae\u57fa\u5e95\u819c\u3002\u4e0b\u5217\u4f55\u8005\u6b63\u78ba\uff1f(1)\u61c9\u505a\u60e1\u6027\u816b\u7624\u7be9\u6aa2; (2)\u61c9\u8a62\u554f\u7528\u85e5\u53f2, \u4e26\u7acb\u523b\u505c\u6b62\u76ee\u524d\u4f7f\u7528\u4e4b\u85e5\u7269 ;(3)\u61c9\u5bc6\u5207\u6ce8\u610f\u75c5\u60a3\u662f\u5426\u767c\u751f\u547c\u5438\u56f0\u96e3 ; (4)\u4ee5\u9ad8\u5291\u91cf\u985e\u56fa\u9187\u6cbb\u7642\uff0c\u4e00\u822c\u90fd\u6703\u5f88\u6709\u6548\u3002\nA. (1)+(3)\nB. (1)+(2)+(4)\nC. (1)+(2)+(3)\nD. (3)+(4)\nE. (1)+(2)+(3)+(4)\n": "(A)", "104-3.\n\u4e0058\u6b72\u7537\u6027\uff0c\u76ae\u819a\u5287\u7662\u53ca\u812b\u5c51\u5df2\u67093\u5e74\u3002\u8fd13\u500b\u6708\u4ee5\u4f86\uff0c\u7531\u6591\u584a\u8b8a\u6210\u5168\u8eab\u767c\u7d05\u3002\u76ae\u819a\u5287\u7662\u81f3\u6703\u5e72\u64fe\u751f\u6d3b\u7684\u7a0b\u5ea6\u3002\u7528\u85e5\u65b9\u9762\u53ea\u6709\u8fd15\u5e74\u4f86\u4f7f\u7528lisinpril\u63a7\u5236\u9ad8\u8840\u58d3\u3002\u8eab\u9ad4\u6aa2\u67e5\u767c\u73fevital sign\u90fd\u6b63\u5e38\u3002\u9ad4\u8868\u5982\u5716\u6240\u793a90%\u76ae\u819a\u90fd\u767c\u7d05\u4e26\u812b\u5c51\uff0c\u800c\u4e14\u6709\u5168\u8eab\u6027\u6dcb\u5df4\u7d50\u816b\u5927, \u624b\u638c\u89d2\u638c\u589e\u539a\uff0c\u8dbe\u7532\u8b8a\u539a\u3002\u4ee5\u4e0b\u4f55\u8005\u662f\u6700\u53ef\u80fd\u7684\u8a3a\u65b7\uff1f\nA. Drug hypersensitivity reaction\nB. Pustular psoriasis\nC. Staphylococcal scalded skin syndrome\nD. Cutaneous T-cell lymphoma\nE. Atopic dermatitis\n": "(D)", "104-4.\n\u4e00 68\u6b72\u7537\u6027\uff0c\u6709\u9577\u671f\u7cd6\u5c3f\u75c5\u75c5\u53f2\uff0c3\u5e74\u5169\u5074\u4e0b\u80a2\u611f\u89ba\u7570\u5e38\uff0c\u5169\u5e74\u52c3\u8d77\u969c\u7919\u3002\u8173\u5e95\u767c\u751f\u5982\u5716\u6240\u793a\u4e0d\u75db\u7684\u6f70\u760d\u5df2\u67096\u500b\u6708\u3002BMI 32\u3002\u4ed6\u4e0d\u62bd\u7159\uff0c\u8173\u5e95\u672a\u53d7\u50b7\u904e\uff0c\u7121\u8ddb\u884c(claudication\uff09,\u7121\u591c\u9593\u8db3\u90e8\u75bc\u75db\u3002\u8db3\u90e8\u6aa2\u67e5\uff0c\u986f\u793adorsalis pedis\u8108\u52d5\u8b8a\u5c0f\uff0c\u8173\u8e1d\u4e26\u7121\u8272\u7d20\u6c88\u6fb1\u3002\u6700\u53ef\u80fd\u7684\u8a3a\u65b7\u662f\u4ec0\u9ebc\uff1f\nA. Venous stasis ulcer\nB. Vasculitic ulcer\nC. Neuropathic ulcer\nD. Ischemic ulcer\nE. Clavus\n": "(C)", "104-5.\n\u4e00\u75c5\u4eba\u56e0leukocytoclastic vasculitis, \u4f7f\u7528dapsone\u6cbb\u7642 25\u5929\u5f8c\u7522\u751ffever\uff0c lymphadenopathy, \u53ca\u5982\u5716\u6240\u793a\u76ae\u75b9\uff0c \u4f46\u7121mucosa ulcer\u3002\u8acb\u554f\u70ba\u78ba\u5b9a\u8a3a\u65b7\uff0c\u4ee5\u4e0b\u6700\u61c9\u7acb\u5373\u505a\u7684\u5169\u9805\u6aa2\u67e5\u662f\u4ec0\u9ebc\uff1f\nA. CBC\uff08\u5305\u62ecdifferential count\uff09\u53caLiver function test\nB. Lymph node biopsy\u53caskin biopy\nC. Blood bacterial culture \u53cafungal culture\nD. MAST \u53caprick test\u6aa2\u6e2c\u904e\u654f\u539f\nE. Patch test\n": "(A)", "104-6.\n\u4e00\u4f4d64\u6b72\u7537\u6027\u56e0\u4e09\u5929\u4ee5\u4f86\u5feb\u901f\u8513\u5ef6\u7684\u5168\u8eab\u767c\u7d05\u3001\u75bc\u75db\u53ca\u878d\u5408\u7684\u81bf\u76b0\u81f3\u6025\u8a3a\u5c31\u8a3a\u3002\u7576\u6642\u9ad4\u6eab\u70ba38.9 C\u3002\u8a62\u554f\u75c5\u53f2\uff0c\u77ad\u89e3\u4ed6\u6709\u8f15\u5fae\u5c0b\u5e38\u6027\u4e7e\u766c\u53ca\u6c23\u5598\u3002\u5c0b\u5e38\u6027\u4e7e\u766c\u7528\u5916\u7528\u85e5\u63a7\u5236\u5f97\u4e0d\u932f\u3002\u4ed6\u56e0\u6c23\u5598\u670d\u7528\u4e86\u5341\u5929\u985e\u56fa\u9187\u81f3\u4e00\u661f\u671f\u524d\u624d\u505c\u85e5\u3002\u8acb\u554f\u6700\u53ef\u80fd\u7684\u8a3a\u65b7\u662f\u4ec0\u9ebc\uff1f\nA. Pustular psoriasis\nB. Acute generalized exanthematous pustulosis\nC. Drug reaction with eosinophilia and systemic symptoms\nD. Sweet syndrome\nE. Candida albicans infection\n": "(A)", "104-7.\n\u4e00\u5973\u6027\u75c5\u60a3\u5168\u8eab\u53ca\u81c9\u90e8\u767c\u751f\u5982\u5716\u6240\u793a\u76ae\u819a\u8b8a\u5316\u5df2\u6709\u4e8c\u5e74, \u4ee5\u4e0b\u4f55\u7a2e\u6aa2\u67e5\u5c0d\u6b64\u75c5\u4eba\u6700\u70ba\u6709\u7528\uff1f\nA. Liver function\nB. Renal function\nC. Thyroid function\nD. Pulmonary function\nE. Muscle power test\n": "(C)", "105-1.\n\u4e0027\u6b72\u7537\u6027\uff0c\u56e0\u5c0f\u817f\u4e00\u500b\u5feb\u901f\u8b8a\u5927\u7684\u75bc\u75db\u6f70\u760d(\u5982\u5716)\u5df2\u67092\u9031\uff0c\u81f3\u6025\u8a3a\u5c31\u91ab\u3002\u525b\u958b\u59cb\u50cf\u500b\u75d8\u5b50\u3002\u8fd12\u500b\u6708\u4f86\uff0c\u4ed6\u6709\u8179\u75db\u53ca\u8178\u9053\u8815\u52d5\u589e\u52a0\u7684\u554f\u984c\u3002\u8eab\u9ad4\u6aa2\u67e5\u4e26\u7121\u767c\u71d2\uff0cvital sign \u6b63\u5e38\u3002\u6f70\u760d\u4e0a\u4e26\u7121\u5316\u81bf\uff0c\u4e5f\u7121\u5ed4\u7ba1\u3002\r\u8acb\u554f\u6700\u53ef\u80fd\u7684\u8a3a\u65b7\u662f\uff1a\nA. Calciphylaxis\nB. Ecthyma gangrenosum\nC. Necrotizing fasciitis\nD. Pyoderma gangrenosum\nE. Stasis ulcer\n": "(D)", "105-2.\n\u6b6450\u6b72\u5973\u6027\u75c5\u60a3\u5148\u6709\u81c9\u90e8\u6f6e\u7d05\u73fe\u8c61\uff0c\u4e00\u5e74\u5f8c\u5f8c\u6f14\u8b8a\u6210\u5982\u5716\u6240\u793a\u4e4b\u76ae\u75b9\uff0c\u9047\u71b1\u6642\u81c9\u6703\u66f4\u7d05\u3002\u6700\u53ef\u80fd\u7684\u8a3a\u65b7\u662f\uff1a\nA. Systemic lupus erythematosus\nB. Solar dermatitis\nC. Rosacea\nD. Dermatomyositis\nE. Ofuji disease\n": "(C)", "105-3.\n\u4e00\u4f4d70\u6b72\u5973\u6027\uff0c\u7f79\u60a3\u7cd6\u5c3f\u75c510\u5e74\uff0c\u672a\u898f\u5247\u5c31\u91ab\u670d\u85e5\uff0c\u4e00\u661f\u671f\u524d\u5728\u4e73\u623f\u4e0b\u51fa\u73fe\u523a\u7662\u7684\u7d05\u8272\u6591(\u5982\u5716)\uff0c\u4e0b\u5217\u4f55\u8005\u70ba\u6700\u53ef\u80fd\u7684\u8a3a\u65b7\uff1f\nA. \u81bf\u75c2\u75b9\uff08impetigo\uff09\nB. \u55ae\u7d14\u6027\u76b0\u75b9\u75c5\u6bd2\u611f\u67d3\uff08herpes simplex virus infection\uff09\nC. \u76ae\u819a\u5ff5\u73e0\u83cc\u611f\u67d3\uff08cutaneous candidiasis\uff09\nD. \u6bdb\u56ca\u708e\uff08folliculitis\uff09\nE. \u9ad4\u766c (tinea corporis)\n": "(C)", "105-4.\n\u5982\u5716\u6240\u793a\u4e4b\u76ae\u819a\u816b\u7624\u662f\uff1f\nA. \u68d8\u7d30\u80de\u764c (squamous cell carcinoma)\nB. \u6ce2\u6587\u6c0f\u75c7 (Bowen's disease)\nC. \u57fa\u5e95\u7d30\u80de\u764c (basal cell carcinoma)\nD. \u60e1\u6027\u9ed1\u7d20\u7624 (malignant melanoma)\nE. \u8840\u7ba1\u8089\u7624 (angiosarcoma)\n": "(C)", "105-5.\n\u4eca\u5e747\u6708\u9593\uff0c\u4e00\u4f4d33\u6b72\u7537\u6027\uff0c\u7a81\u7136\u767c\u751f\u5982\u5716\u6240\u793a\u4e4b\u5168 \u8eab\u76ae\u819a\u7d05\u75b9, \u611f\u89ba\u65e5\u66ec\u5f8c\u6703\u66f4\u7d05\u66f4\u7662\u3002\u4ee5\u4e0b\u4f55\u8005\u6709\u52a9\u65bc\u8a3a\u65b7\uff1a\nA. \u8a62\u554f\u904e\u53bb2\u5e74\u898f\u5247\u4f7f\u7528\u7684\u85e5\u7269\u540d\u7a31\nB. \u8a62\u554f\u8fd1\u4e8c\u9031\u65b0\u7528\u4e4b\u85e5\u7269\u540d\u7a31\nC. \u505aCBC \u53cadifferential count\nD. \u505a\u809d\u6a5f\u80fd\u6aa2\u67e5\nE. \u505a\u5149\u8cbc\u819a\u8a66\u9a57 (photo-patch test)\n": "(B)", "105-6.\n\u4e00\u4f4d40\u6b72\u5973\u6027\uff0c\u8fd1\u534a\u5e74\u4f86\u5728\u81c9\u90e8\u3001\u9838\u90e8\u8207\u524d\u80f8\u90e8\u76ae \u819a\uff0c\u51fa\u73fe\u5982\u5716\u4e4b\u8868\u73fe\u3002\u95dc\u65bc\u8a72\u60a3\u8005\u8a3a\u65b7\u8207\u6cbb\u7642\u7684\u63cf\u8ff0\uff0c\u4f55\u8005\u6b63\u78ba\uff1f(\u8acb\u9078\u51fa\u5168\u90e8\u7b54\u6848) 1.\u76ae\u819a\u75c5\u7406\u6709\u660e\u986f\u767c\u708e\u53cd\u61c9\uff0c\u9020\u6210\u8272\u7d20\u812b\u5931 2.\u76ae\u819a\u9ed1\u8272\u7d20\u7d30\u80de\u6d88\u5931\u6216\u6e1b\u5c11 3.\u61c9\u505a\u7532\u72c0\u817a\u529f\u80fd\u8207\u6297\u9ad4\u7684\u6aa2\u67e5 4.UVB1 \uff08311nm\uff09\u7a84\u6ce2\u7d2b\u5916\u5149\u53ef\u4fc3\u9032\u8272\u7d20\u56de\u5fa9\u3002\nA. 1+3\nB. 1+4\nC. 1+2+3\nD. 2+3+4\nE. 1+2+3+4\n": "(D)", "105-7.\n\u4e0065\u6b72\u7537\u6027\uff0c\u5148\u6709\u9f3b\u5c16\u75bc\u75db\u7136\u5f8c\u53f3\u773c\u9031\u75bc\u75db\u4f86\u5c31\u8a3a\u3002\u8eab\u9ad4\u6aa2\u67e5\u767c\u73fevital sign\u90fd\u6b63\u5e38\u3002\u5728\u9f3b\u5c16\u53ca\u53f3\u773c\u9031\u570d\u6709\u5e95\u90e8\u7d05\u816b\u7684\u6210\u7c07\u5c0f\u6c34\u76b0\u3002\u4ee5\u4e0b\u4f55\u8005\u70ba\u6070\u7576\u8655\u7f6e\uff1f 1. \u5857\u62b9\u985e\u56fa\u9187\u85e5\u818f\uff1b 2. \u7acb\u523b\u505aophthalmic consultation\uff1b 3. \u505abacterial culture, \u4e26\u7d66\u4e88cephalexin\uff1b 4. \u7d66\u4e88\u53e3\u670dvalacyclovir; 5. IV push acyclovir\nA. 1+3\nB. 2+4\nC. 1+2+3\nD. 1+2+5\nE. 1+2+3+4+5\n": "(B)", "106-1.\n\u4e00\u4f4d40\u6b72\u5973\u6027\uff0c\u8fd1\u534a\u5e74\u4f86\u5728\u81c9\u90e8\u3001\u9838\u90e8\u8207\u524d\u80f8\u90e8\u76ae\u819a\uff0c\u51fa\u73fe\u5982\u5716\u4e4b\u8868\u73fe\u3002\u95dc\u65bc\u8a72\u60a3\u8005\u8a3a\u65b7\u8207\u6cbb\u7642\u7684\u63cf\u8ff0\uff0c\u4f55\u8005\u6b63\u78ba\uff1f(\u61c9\u9078\u51fa\u5168\u90e8\u7b54\u6848) (1)\u76ae\u819a\u75c5\u7406\u6709\u660e\u986f\u767c\u708e\u7d30\u80de\u6d78\u6f64\uff0c\u9020\u6210\u8272\u7d20\u812b\u5931; (2) \u6bdb\u56ca\u4e4b\u9ed1\u8272\u7d20\u7d30\u80de\u6d88\u5931; (3) \u8868\u76ae\u57fa\u5e95\u5c64\u4e4b\u9ed1\u8272\u7d20\u7d30\u80de\u6d88\u5931;  (4) \u61c9\u505a\u7532\u72c0\u817a\u529f\u80fd\u8207\u6297\u9ad4\u7684\u6aa2\u67e5; (5) UVB1(311nm)\u7a84\u6ce2\u7d2b\u5916\u5149\u53ef\u4fc3\u9032\u8272\u7d20\u56de\u5fa9\nA. (1)+(2)+(3)\nB. (2)+(3)+(4)\nC. (1)+(5)\nD. (2)+(5)\nE. (3)+(4)+(5)\n": "(E)", "106-2.\n\u4e0070\u6b72\u7537\u6027\uff0c\u56e0\u53f3\u773c\u9031\u53ca\u53f3\u5074\u982d\u90e8\u75bc\u75db\u4f86\u5c31\u8a3a\u3002\u8eab\u9ad4\u6aa2\u67e5\u767c\u73fevital sign\u90fd\u6b63\u5e38\u3002\u5728\u9f3b\u5c16\u53ca\u53f3\u773c\u9031\u570d\u6709\u5e95\u90e8\u7d05\u816b\u7684\u6210\u7c07\u5c0f\u6c34\u76b0\u3002\u4ee5\u4e0b\u4f55\u8005\u70ba\u6070\u7576\u8655\u7f6e\uff1f(1)\u5857\u62b9\u985e\u56fa\u9187\u85e5\u818f\uff1b(2)\u505abacterial culture, \u4e26\u7d66\u4e88cephalexin\uff1b(3)\u7acb\u523b\u505aophthalmic consultation\uff1b(4)\u505a\u814e\u529f\u80fd\u6aa2\u67e5; (5)\u7d66\u4e88\u53e3\u670dvalacyclovir\u6216\u975c\u8108\u9ede\u6ef4\u6ce8\u5c04acyclovir\nA. (1)+(2)+(3)\nB. (2)+(3)+(4)\nC. (1)+(5)\nD. (2)+(5)\nE. (3)+(4)+(5)\n": "(E)", "106-3.\n\u4e00\u4f4d30\u6b72\u7537\u6027\u8d74\u6771\u5357\u4e9e\u65c5\u904a\uff0c\u56de\u570b\u5f8c\u56db\u500b\u6708\u51fa\u73fe\u624b\u638c\u8173\u638c\u53ca\u5168\u8eab\u5e36\u6709\u53e4\u9285\u8272\u7684\u812b\u5c51\u4e18\u75b9\uff0c\u6b64\u76ae\u75b9\u5df2\u6301\u7e8c2\u500b\u6708(\u5982\u5716\u793a)\u3002\u4ee5\u4e0b\u4f55\u8005\u4e0d\u662f\u5fc5\u8981\u8655\u7f6e? (1) \u6aa2\u6e2cmeasles IgM; (2)\u8a62\u554f\u6027\u884c\u70ba\u53f2; (3)\u6aa2\u6e2cTPHA; (4) \u6aa2\u6e2cVDRL\u6216RPR; (5)\u6aa2\u6e2crubella IgM\nA. (1)+(2)+(3)\nB. (2)+(3)+(4)\nC. (1)+(5)\nD. (2)+(5)\nE. (3)+(4)+(5)\n": "(C)", "106-4.\n\u4e0057\u6b72\u6709\u7159\u766e\u7684\u7537\u6027\uff0c10\u5e74\u524d\u6212\u7159\u3002\u4e0b\u5507\u767c\u751f\u5982\u5716\u6240\u793a\u4e4b\u76ae\u819a\u816b\u7624\u5df2\u67093\u500b\u6708\u3002\u6700\u53ef\u80fd\u7684\u8a3a\u65b7\u662f\uff1f\nA. \u68d8\u7d30\u80de\u764c (squamous cell carcinoma)\nB. \u65e5\u5149\u6027\u53e3\u5507\u708e(actinic chelitis)\nC. \u55ae\u7d14\u76b0\u75b9 (herpes simplex)\nD. \u60e1\u6027\u9ed1\u7d20\u7624 (malignant melanoma)\nE. \u81bf\u75c2\u75b9 (impetigo)\n": "(A)", "106-5.\n\u6b6422\u6b72\u7537\u6027\u75c5\u60a3\u540c\u6642\u6709\u5634\u5507\u6210\u7c07\u5c0f\u6c34\u76b0\uff0c\u53ca\u624b\u638c\u5982\u5716\u6240\u793a\u6a19\u9776\u6a23\u76ae\u75b9\uff0c\u6700\u53ef\u80fd\u7684\u611f\u67d3\u75c5\u539f\u662f\uff1a\nA. Herpes simplex virus\nB. Parvovirus B19\nC. Streptococcus, group A\nD. Varicella zoster virus\nE. Staphylococcus aureus\n": "(A)", "106-6.\n\u5982\u5716\u6240\u793a\u76ae\u75b9\u5df2\u67095\u5e74\uff0c\u4ee5\u4e0b\u6558\u8ff0\u4f55\u8005\u70ba\u975e\uff1f\nA. \u5e38\u5728\u982d\u76ae\u767c\u751f\nB. Anti-IL12/IL-23, anti-IL17 \u662f\u6709\u6548\u7684\u751f\u7269\u88fd\u5291\nC. \u53e3\u670d\u985e\u56fa\u9187\u662f\u9996\u9078\u6cbb\u7642\nD. \u6bd4\u4e00\u822c\u4eba\u6613\u4f75\u6709\u5fc3\u8840\u7ba1\u75be\u75c5\nE. \u6bd4\u4e00\u822c\u4eba\u6613\u4f75\u6709\u65b0\u9673\u4ee3\u8b1d\u75c7\u5019\u7fa4\n": "(C)", "106-7.\n\u6b6445\u6b72\u5a66\u5973\u65c5\u884c\u5c45\u4f4f\u65c5\u9928\u5f8c\u65bc\u8179\u90e8\u767c\u751f\u5982\u5716\u6240\u793a3\u9846\u9802\u90e8\u6709\u5c0f\u6c34\u76b0\u7684\u6703\u7662\u76ae\u75b9\uff0c\u8207\u5979\u540c\u884c\u7684\u5148\u751f\u4e26\u672a\u767c\u751f\u540c\u6a23\u76ae\u75b9\u3002\u61c9\u5982\u4f55\u8655\u7f6e\uff1f\nA. \u5857\u62b9\u985e\u56fa\u9187\u85e5\u818f\nB. \u5857\u62b9permethrin \u85e5\u818f\nC. \u5168\u8eab\u5857\u62b9benzyl benzoate \u85e5\u6c34\nD. \u53e3\u670d\u985e\u56fa\u9187\nE. \u53e3\u670divermectin\n": "(A)", "107-1.\n\u4e0038\u6b72\u5973\u6027\u56e0pyelonephritis\u4f7f\u7528trimethoprim-sulfamethoxazole\u6cbb\u76423\u661f\u671f\u5f8c\u767c\u751f\u5168\u8eab\u6027\u76ae\u75b9\u53ca\u81c9\u90e8\u816b\u8139\uff0c\u4f46\u7121\u547c\u5438\u56f0\u96e3\u3002\u5979\u4e26\u672a\u540c\u6642\u4f7f\u7528\u5176\u4ed6\u85e5\u7269\uff0c\u4e5f\u7121\u5176\u4ed6\u75be\u75c5\u3002\u7406\u5b78\u6aa2\u67e5\u767c\u73fe\uff1a\u9ad4\u6eab38.5\u2103, \u7121\u9ecf\u819c\u7834\u640d\uff0c\u5728\u524d\u9838\u53ca\u814b\u4e0b\u67093cm\u5927\u5c0f\u7684\u6dcb\u5df4\u7d50\uff0ccostal margin \u4e0b\u65b94cm\u6478\u5230liver edge\u3002\u76ae\u75b9\u5982\u5716\u6240\u793a\u3002\u8acb\u554f\u5982\u4e0b\u54ea\u4e9b\u6aa2\u67e5\u90fd\u662f\u5fc5\u9808\u505a\u7684\uff1f(1). CBC and differential count (2). Liver chemistry test (3). Lymph node biopsy (4). Skin biopsy (5). Serum IgE\nA. (1)+(2)\nB. (3)+(4)\nC. (4)+(5)\nD. (1)+(2)+(3)\nE. (3)+(4)+(5)\n": "(A)", "107-2.\n\u4e00\u7537\u6027\u75c5\u60a3\u767c\u751f\u65bc\u5168\u8eab(\u5305\u62ec\u624b\u638c\u8173\u638c)\u4e4b\u5982\u5716\u4e0d\u7662\u68d5\u7d05\u8272\u5e36\u5c51\u6591\u72c0\u4e18\u75b9\uff08maculopaules\uff09 \u5df2\u67091\u500b\u6708\uff0c\u7121\u7528\u85e5\u53f2\uff0c\u6709\u5168\u8eab\u6027\u6dcb\u5df4\u7d50\u816b\u5927, \u7d66\u4e88antihistamine\u672a\u898b\u6539\u5584\u3002\u75c5\u60a3\u53ca\u7537\u6027\u6027\u4f34\u4fb6RPR, TPHA\u5747\u70ba\u967d\u6027\uff0c\u4ee5\u4e0b\u4f55\u8005\u4e0d\u6b63\u78ba\uff1f (1). \u65bd\u6253benzathine penicillin G \u6cbb\u7642 (2). \u6aa2\u6e2cTPHA\u6216TPPA\uff0c\u964d\u4f4e4\u500d\u4ee5\u4e0a\u53ef\u4ee5\u78ba\u5b9a\u6cbb\u7642\u6210\u6548 (3). \u6aa2\u6e2cRPR\u6216VDRL\uff0c\u964d\u4f4e4\u500d\u4ee5\u4e0a\u53ef\u4ee5\u78ba\u5b9a\u6cbb\u7642\u6210\u6548 (4). \u6aa2\u6e2c anti-HSV2 IgG \u53ef\u8b49\u660e\u73fe\u5728\u4e5f\u6709HSV2 infection (5). \u5373\u4f7f\u4e0d\u6cbb\u7642\uff0c\u76ae\u75b9\u4e5f\u53ef\u80fd\u81ea\u52d5\u6d88\u5931\nA. (1)+(3)+(5)\nB. (2)+(4)\nC. (3)+(5)\nD. (1)+(3)\nE. (1)+(5)\n": "(B)", "107-3.\n52\u6b72\u7537\u6027\u6709acute myeloid leukemia, \u5728\u958b\u59cb\u5316\u764210\u5929\u5f8c\u767c\u751fneutropenic fever, \u4e14\u5728\u524d\u80f8\u3001\u5f8c\u80cc\u53ca\u624b\u81c2\u767c\u751f\u5e7e\u500b\u76ae\u75b9\u3002\u7406\u5b78\u6aa2\u67e5\u986f\u793a\uff1a\u9ad4\u6eab38.4\u2103\uff0c\u8840\u58d3110/70 mmHg, \u8108\u640f 95/min, \u547c\u543818/min. \u4ee3\u8868\u6027\u76ae\u75b9\u5982\u5716\u6240\u793a\uff0c\u5be6\u9a57\u5ba4\u6aa2\u67e5\uff1aHb 8.2g/dL\u3001WBC 400/ uL with 95% neutrophils\u3001Platelet 10,000/ uL\u3001Metabolic profile: normal\u3001Urine analysis: normal\u3001Chest x-ray: normal\u3001Blood culture: negative\u3002\u6700\u53ef\u80fd\u7684\u8a3a\u65b7\u662f\u4ec0\u9ebc\uff1f\nA. Candidiasis\nB. Keratoacanthoma\nC. Pyogenic granuloma\nD. Sweet syndrome\nE. Deep fungal infection\n": "(D)", "107-4.\n\u6b64\u4e00\u75c5\u60a3\u767c\u751f\u5982\u5716\u6240\u793a\u7d05\u8272\u812b\u5c51\u76ae\u75b9\u65bc\u7709\u6bdb\u53ca\u7709\u5fc3, \u51ac\u5b63\u589e\u60e1\u3002\r\u8acb\u554f\u4ee5\u4e0b\u4f55\u8005\u70ba\u6700\u9069\u7576\u7684\u8655\u7f6e\uff1f\nA. Benzoyl peroxide\nB. Ketoconazole cream \u53ca low potency steroid cream\nC. Metronidazole gel\nD. Mupirocin ointment\nE. Clobetasol-17-propionate ointment\n": "(B)", "107-5.\n67\u6b72\u7537\u6027\u5e7e\u661f\u671f\u524d\u767c\u751f\u5982\u5716\u6240\u793a\u8173\u8e1d\u5916\u5074\u4e4b\u6f70\u760d\u3002\u6b64\u6f70\u760d\u6703\u75db\uff0c\u800c\u4e14\u5c07\u8173\u62ac\u9ad8\u6642\u66f4\u75db\u3002\u4ed6\u6709\u9ad8\u8840\u58d3\uff0c\u6bcf\u5e74\u62bd\u715940\u5305\uff0camlodipine\u662f\u552f\u4e00\u4f7f\u7528\u7684\u85e5\u7269\u3002\u8acb\u554f\u4e0b\u5217\u4f55\u8005\u662f\u6700\u9700\u8981\u7684\u8655\u7f6e\uff1f\nA. \u5728\u6f70\u760d\u908a\u7de3\u505a\u5207\u7247\u6aa2\u67e5\nB. \u7a7f\u5f48\u6027\u896a\nC. \u91cf\u6e2c ankle-brachial index\nD. \u53e3\u670d\u6297\u751f\u7d20\nE. \u505a\u7d30\u83cc\u57f9\u990a\n": "(C)", "107-6.\n80\u6b72\u5973\u6027\u5728\u4e00\u9031\u524d\u767c\u73fe\u76ae\u819a\u5f88\u7662\uff0c\u7136\u5f8c\u5728\u524d\u80f8\u3001\u8179\u90e8\u3001\u56db\u80a2\u767c\u751f\u5982\u5716\u6240\u793a\u4e0d\u6613\u7834\u6389\u7684\u6c34\u76b0\uff0c\u53e3\u8154\u9ecf\u819c\u6b63\u5e38\u3002\u8acb\u554f\u6700\u53ef\u80fd\u7684\u8a3a\u65b7\u662f\u4ec0\u9ebc\uff1f\nA. Bullous pemphigoid\nB. Pemphigus vulgaris\nC. Pemphigus foliaceus\nD. Toxic epidermal necrolysis\nE. Stevens-Johnson syndrome\n": "(A)", "107-7.\n32\u6b72\u5973\u6027\u5728\u624b\u8098\u3001\u819d\u84cb\u3001\u982d\u76ae\u767c\u751f\u5287\u7662\u7684\u76ae\u75b9\u5df2\u67096\u500b\u6708\uff0c\u4e26\u6709irritable bowel syndrome \u7684\u75c5\u53f2\uff0c\u53e3\u8154\u9ecf\u819c\u6b63\u5e38\uff0c\u8fd16\u500b\u6708\u9ad4\u91cd\u6e1b\u8f154.5kg\uff0c\u7406\u5b78\u6aa2\u67e5\uff1a\u76ae\u75b9\u5982\u5716\u6240\u793a\uff0c\u5176\u9918\u6b63\u5e38\u3002\u6700\u53ef\u80fd\u540c\u6642\u4f75\u6709\u7684\u75be\u75c5\u662f\u90a3\u500b\uff1f\nA. Celiac disease\nB. Hepatitis C\nC. Non-Hodgkin lymphoma\nD. Ulcerative colitis\nE. Diabetes mellitus\n": "(A)", "108-1.\n\u95dc\u65bc\u75a5\u7621(scabies)\u4ee5\u4e0b\u4f55\u8005\u932f\u8aa4? (1)\u611f\u67d3\u4eba\u985e\u4e4b\u75a5\u87f2(Sarcoptes scabei var. hominis)\u751f\u547d\u5468\u671f\u7d04 30 \u5929\uff1b(2)\u75a5\u87f2\u96e2\u958b\u4eba\u9ad4\u76ae\u819a\u6700\u591a\u53ef\u5b58\u6d3b 3 \u5929\uff1b(3)\u6297\u75a5\u85e5\u818f\u5c40\u90e8\u539a\u5857\u65bc\u60a3\u90e8\u5c31\u53ef\u5fb9\u5e95\u6bba\u75a5\u87f2\uff1b(4)\u5982\u78ba\u5b9a\u611f\u67d3\uff0c\u5bb6\u4e2d\u5bf5\u7269(\u5982\u8c93\u72d7)\u4e5f\u9808\u4e00\u4f75\u6cbb\u7642\uff1b(5)\u6210\u4eba\u597d\u767c\u65bc\u624b\u81c2\u3001\u817f\u90e8\u3001\u80cc\u90e8\u53ca\u81c9\u90e8\nA. (1)+(2)+(3)\nB. (2)+(3)+(4)\nC. (1)+(3)\nD. (2)+(4)\nE. (3)+(4)+(5)\n": "(E)", "108-2.\n\u975e\u7622\u75d5\u578b\u843d\u9aee( nonscarring alopecia )\u53ef\u80fd\u4e4b\u539f\u56e0? (1)Alopecia areata\uff1b(2)Syphilis\uff1b(3)Androgenetic alopecia\uff1b(4)Discoid lupus erythematosus\uff1b(5)Lichen planopilaris\nA. (1)+(2)+(3)\nB. (2)+(3)+(4)\nC. (1)+(3)\nD. (2)+(4)\nE. (3)+(4)+(5)\n": "(A)", "108-3.\n\u4e0b\u5217\u95dc\u65bc\u8541\u9ebb\u75b9(urticaria)\u4e4b\u6558\u8ff0\uff0c\u4f55\u8005\u70ba\u975e\uff1f\nA. \u5e38\u7528\u6297\u7d44\u7e54\u80fa\u85e5\u7269\u6cbb\u7642\nB. \u6240\u6709\u7684\u75c5\u4eba\u7686\u53ef\u627e\u51fa\u539f\u56e0\nC. \u4f75\u7528aspirin\uff0c\u5e38\u4f7f\u6b64\u75c5\u60e1\u5316\nD. \u8541\u9ebb\u75b9\u4e4b\u55ae\u4e00\u75c5\u7076\u5e38\u572824 \u5c0f\u6642\u5167\u6d88\u5931\nE. \u61c9\u5148\u8a62\u554f\u75c5\u4eba\u7684\u7528\u85e5\u53f2\n": "(B)", "108-4.\n\u4e00\u4f4d\u5be6\u7fd2\u91ab\u5e2b\u7a81\u7136\u5728\u81c9\u90e8\u53ca\u8ec0\u5e79\u767c\u751f\u5982\u5716\u793a\u7684\u76ae\u75b9\uff0c\u4f75\u6709\u767c\u71d2\uff0c\u6700\u53ef\u80fd\u7684\u8a3a\u65b7\u662f\uff1f\nA. Varicella\nB. Stevens-Johnson syndrome\nC. Rubella\nD. Sudamina\nE. Pityriasis lichenoides et varioliformis acuta\n": "(A)", "108-5.\n30\u6b72\u7537\u6027, \u76ae\u819a\u75c5\u8b8a\u5982\u5716, \u4ee5\u4e0b\u4f55\u8005\u70ba\u5fc5\u9700\u4e4b\u8655\u7f6e\uff1f(1) \u62bd\u8840\u6aa2\u67e5\u6709\u7121HIV\u611f\u67d3\uff1b (2) \u8a62\u554f\u6027\u884c\u70ba\u53f2\uff1b(3) \u62bd\u8840\u6aa2\u67e5\u6709\u7121\u6885\u6bd2\uff1b(4) \u5207\u53d6\u7d44\u7e54\u4f5c\u75c5\u7406\u6aa2\u67e5\nA. (1)+(3)\nB. (2)+(4)\nC. (1)+(2)+(3)\nD. (4)\nE. (1)+(2)+(3)+(4)\n": "(C)", "108-6.\n\u6b6450\u6b72\u5973\u6027\u75c5\u60a3\u5148\u6709\u81c9\u90e8\u6f6e\u7d05\u73fe\u8c61\uff0c\u4e00\u5e74\u5f8c\u5f8c\u6f14\u8b8a\u6210\u5982\u5716\u6240\u793a\u4e4b\u76ae\u75b9\uff0c\u9047\u71b1\u6642\u81c9\u6703\u66f4\u7d05\u3002\u6700\u53ef\u80fd\u7684\u8a3a\u65b7\u662f\uff1a\nA. Systemic lupus erythematosus\nB. Solar dermatitis\nC. Rosacea\nD. Dermatomyositis\nE. Ofuji disease\n": "(C)", "108-7.\n\u5982\u5716\u6240\u793a\u81c9\u90e8\u7684\u6162\u6027\u589e\u5927\u55ae\u4e00\u816b\u584a\uff0c\u4e0b\u5217\u4f55\u8005\u662f\u6700\u53ef\u80fd\u7684\u8a3a\u65b7\uff1f\nA. Basal cell carcinoma\nB. Melanoma\nC. Seborrheic keratosis\nD. Sebaceous carcinoma\nE. Squamous cell carcinoma\n": "(A)", "109-194.\u4e00\u4f4d36\u6b72\u5973\u6027\u51fa\u73fe\u5982\u5716\u4e4b\u5287\u7662\u76ae\u819a\u75c5\u8b8a \uff0c\u75c5\u7076\u5f80\u5f80\u5728 2-4\u5c0f\u6642\u5019\u6d88\u5931 \uff0c\u4f46\u6703\u53cd\u53cd\u8986\u8986\u767c\u4f5c \uff0c\u90544\u5e74\u4e4b\u4e45\uff0c\u4f7f\n\u5979\u5e38\u5e38\u7121\u6cd5\u5165\u7720 \uff0c\u8acb\u554f\u6700\u53ef\u80fd\u7684\u8a3a\u65b7\u70ba\u4f55 \uff1f   \nA.\u7570\u4f4d\u6027\u76ae\u819a\u708e (atopic dermatitis)\nB.\u5c0b\u5e38\u6027\u9b5a\u9c57\u766c (ichthyosis vulgaris)\nC.\u6162\u6027\u8541\u9ebb\u75b9 (Chronic urticaria)\nD.\u75a5\u7621 (Scabies)\nE.\u6162\u6027\u6fd5\u75b9 (Chronic eczema)\n": "[C]", "109-195.\u627f\u4e0a\uff0c\u8acb\u554f\u76ee\u524d\u6700\u5efa\u8b70\u7684\u9996\u9078\u6cbb\u7642\u65b9\u5f0f\u70ba\u4f55\uff1f       \nA.\u53e3\u670d\u6297\u7d44\u7e54\u80fa\nB.\u53e3\u670d\u985e\u56fa\u9187\nC.\u5c40\u90e8\u985e\u56fa\u9187\nD.\u514d\u75ab\u6291\u5236\u5291 (\u5982\u74b0\u5b62\u9748cyclosporine)\nE.\u5c40\u90e8\u6297\u7d44\u7e54\u80fa\n": "[A]", "109-196.\u81fa\u7063\u4eba\u6700\u5e38\u898b\u7684\u76ae\u819a\u9ed1\u8272\u7d20\u7d30\u80de\u764c (Cutaneous melanoma) \u662f\u54ea\u4e00\u578b\uff1f    \nA.\u7d50\u7bc0\u578b\u9ed1\u8272\u7d20\u7d30\u80de\u764c (nodular melanoma)\nB.\u80a2\u7aef\u9ed1\u75e3\u578b\u9ed1\u8272\u7d20\u7d30\u80de\u764c (acral lentiginous melanoma)\nC.\u8868\u6dfa\u64f4\u6563\u578b\u9ed1\u8272\u7d20\u7d30\u80de\u764c (superficial spreading melanoma)\nD.\u60e1\u6027\u9ed1\u75e3\u578b\u9ed1\u8272\u7d20\u7d30\u80de\u764c (lentigo maligna melanoma)\nE.\u9ecf\u819c\u578b\u9ed1\u8272\u7d20\u7d30\u80de\u764c (mucousal melanoma)\n": "[B]", "109-197.\u4e0b\u5217\u6709\u95dc\u5224\u65b7\u662f\u5426\u70ba\u76ae\u819a\u9ed1\u8272\u7d20\u7d30\u80de\u764c (Cutaneous melanoma) \u7684ABCDE\u53e3\u8a23 \uff0c\u54ea\u4e9b\u8981\u8003\u616e\u60e1\u6027 \uff1f(1) \nA:\u5c0d\u7a31 (Asymmetry )\uff0c\u75c5\u7076\u672c\u8eab\u5de6\u53f3\u5c0d\u7a31\u7684\u6642\u5019; (2) B\u908a\u7de3 (Border)\uff0c\u75c5\u7076\u908a\u7de3\u898f\u5247\u7684\u6642\u5019; (3) C\u984f\u8272 \n(Color)\uff0c\u75c5\u7076\u8272\u6fa4\u5747\u52fb\u7684\u6642\u5019; (4) D\u76f4\u5f91 (Diameter) \u5927\u65bc6 mm\u7684\u6642\u5019; (5) E\u6f14\u8b8a (Evolving )\uff0c\u75c5\u7076\u5927\n\u5c0f\u3001\u5f62\u72c0\u3001\u984f\u8272\u6709\u8b8a\u5316 \uff0c\u6216\u662f\u9686\u8d77 \u3001\u51fa\u8840\u6642   \nA.(1)+(2)+(3)\nB.(2)+(3)+(4)\nC.(2)+(3)\nD.(4)+(5)\nE.(2)+(5)\n": "[D]", "109-198.\u4e0b\u5217\u6709\u95dc\u57fa\u5e95\u7d30\u80de\u764c (Basal cell carcinoma) \u7684\u81e8\u5e8a\u8868\u73fe \uff0c\u4f55\u8005\u6b63\u78ba \uff1f(1) \u8868\u6dfa\u578b (superficial) \u57fa\u5e95\u7d30\u80de\u764c\n\u6700\u60e1\u6027\uff0c\u597d\u767c\u65bc\u56db\u80a2\u672b\u68a2 \uff0c\u81e8\u5e8a\u4e0a\u50cf\u6fd5\u75b9\u75c5\u7076; (2) \u7d50\u7bc0\u578b (nodular) \u57fa\u5e95\u7d30\u80de\u764c\u81e8\u5e8a\u4e0a\u5e38\u898b\u70ba\u7de9\u6162\u9577\u5927\u7684\n\u7d50\u7bc0\uff0c\u5e36\u6709\u73cd\u73e0\u5149\u6fa4 \uff0c\u908a\u7de3\u9686\u8d77 \uff0c\u4e14\u6709\u64f4\u5f35\u8840\u7d72; (3) \u8272\u7d20\u578b (pigmented) \u57fa\u5e95\u7d30\u80de\u764c\u985e\u4f3c\u9ed1\u8272\u7d20\u7d30\u80de\n\u764c\uff0c\u6975\u6613\u8f49\u79fb; (4) \u786c\u76ae\u578b (morpheaform) \u57fa\u5e95\u7d30\u80de\u764c \uff0c\u81e8\u5e8a\u8868\u73fe\u70ba\u55ae\u4e00 \u3001\u6241\u5e73\u6216\u840e\u7e2e\u50cf\u75a4\u75d5\u822c\u7684\u677f\u584a\u75c5\n\u7076\uff0c\u5177\u4fb5\u8972\u6027   \nA.(1)+(3)\nB.(2)+(4)\nC.(1)+(4)\nD.(2)+(3)\nE.(3)+(4)\n": "[B]", "109-199.\u4e00\u4f4d56\u6b72\u7537\u6027\u51fa\u73fe\u5982\u5716\u75c5\u7076\uff0c\u8acb\u554f\u6700\u53ef\u80fd\u8a3a\u65b7\uff0c\u8207\u6700\u91cd\u8981\u7684\u81e8\u5e8a\u7279\u5fb5\u70ba\u4f55\uff1f    \nA.\u7d05\u6591\u6027\u72fc\u7621 (lupus erythematosus)\uff1b\u51cd\u7621\u578b\u7d05\u6591\u6027\u72fc\u7621 (chilblain lupus erythematosus) \u75c5\u7076\nB.\u76ae\u808c\u708e (dermatomyositis)\uff1bGottron\u6c0f\u5fb5\u5019 (Gottron's sign)\nC.\u985e\u98a8\u6ebc\u6027\u95dc\u7bc0\u708e (rheumatoid arthritis)\uff1b\u985e\u98a8\u6fd5\u6027\u7d50\u7bc0 (rheumatoid nodules)\nD.\u5168\u8eab\u6027\u786c\u76ae\u75c7 (systemic scleroderma)\uff1b\u624b\u6307\u786c\u5316 (sclerodactyly)\u3001\u624b\u6307\u6f70\u760d (digital ulcerations)\nE.\u611f\u67d3\u6027\u5fc3\u5167\u819c\u708e (infective endocarditis)\uff1bJaneway lesions\n": "[D]", "109-200.\u4e00\u4f4d26\u6b72\u7537\u6027\u51fa\u73fe\u5982\u5716\u75c5\u7076\uff0c\u8acb\u554f\u6700\u53ef\u80fd\u8a3a\u65b7\u70ba\u4f55\uff1f    \nA.\u5713\u76e4\u578b\u7d05\u6591\u6027\u72fc\u7621 (discoid lupus erythematosus)   \nB.\u76ae\u808c\u708e (dermatomyositis)\nC.\u6df1\u90e8\u771f\u83cc\u611f\u67d3 (deep fungal infection)\nD.\u786c\u76ae\u75c7 (scleroderma)\nE.\u840e\u7e2e\u6027\u75a4\u75d5 (atrophic scar)": "[A]", "110-156.31\u6b72\u7537\u6027\u4e3b\u8a34\u5168\u8eab\u7121\u75c7\u72c0\u76ae\u75b9 2\u500b\u6708(\u5982\u5716\u793a)\uff0c\u56db\u500b\u6708\u524d\u6709\u6771\u5357\u4e9e\u65c5\u904a\u53f2 \uff0c\u4e26\u66fe\u53c3\u52a0\u7576\u5730\u7684\u5c71\u5340\u5065\u884c \uff0c\u4ee5\n\u4e0b\u4f55\u8005\u662f\u5c0d\u5176\u8a3a\u65b7\u6700\u9700\u8981\u7684\u6aa2\u67e5 ?   \nA.\u76ae\u5c51KOH\u986f\u5fae\u93e1\u6aa2\u67e5\u3002\nB.\u76ae\u819a\u7d44\u7e54\u5207\u7247\u7684\u975e\u5178\u578b\u5206\u679d\u687f\u83cc\u7684\u7d44\u7e54\u67d3\u8272\u53ca\u57f9\u990a\u3002\nC.\u62bd\u8840\u6aa2\u6e2cVDRL/RPR \u53caTPPA/TPHA\u6548\u50f9\u3002\nD.\u62bd\u8840\u6aa2\u6e2cBorrelia burgdorferi IgM \u53caIgG\u8840\u6e05\u6297\u9ad4\u3002\nE.\u4f0d\u6c0f\u71c8(Wood's light)\u6aa2\u67e5\u3002\n": "[C]", "110-157.20\u6b72\u7537\u6027\u51fa\u751f\u6642\u5728\u81c0\u90e8\u5169\u5074\u53ca\u80cc\u90e8\u767c\u73fe\u6578\u500b\u767d\u6591 \uff0c\u5169\u500b\u6708\u5927\u6642\u958b\u59cb\u6709\u7672\u7647\u767c\u4f5c \uff0c\u4e00\u76f4\u4ee5\u6297\u7672\u7647\u85e5\u63a7\u5236 \u3002\u81c9\n\u90e8 (\u5716\u4e00) \u53ca\u4e0b\u80cc\u90e8 (\u5716\u4e8c) \u5728\u5b69\u7ae5\u671f\u51fa\u73fe\u591a\u767c\u6027\u76ae\u819a\u816b\u7624 \uff0c5\u5e74\u524d\u8179\u90e8MRI\u5f71\u50cf\u6aa2\u67e5\u767c\u73fe\u814e\u81df\u816b\u7624\u53ca\u80f0\u81df\u982d\n\u90e8\u816b\u7624\u3002\u80f0\u81df\u816b\u7624\u9010\u6f38\u8b8a\u5927\u52307 cm \uff0c\u4e26\u4f34\u6709\u8179\u75db \uff0c\u7d93\u5167\u8996\u93e1\u8d85\u97f3\u6ce2\u6307\u5f15\u7d30\u91dd\u62bd\u5438\u6aa2\u67e5 \uff0c\u75c5\u7406\u5831\u544a\u986f\u793a\u70ba\n\u795e\u7d93\u5167\u5206\u6ccc\u7624 (neuroendocrine tumor )\u3002\u8acb\u554f\u7d9c\u5408\u4e0a\u8ff0\u6b64\u4f4d\u75c5\u4eba\u6700\u53ef\u80fd\u7684\u8a3a\u65b7\u70ba\u4f55 \uff1f   \nA.\u795e\u7d93\u7e96\u7dad\u7624\u75c7\u7b2c\u4e00\u578b (Neurofibromatosis type 1)\u3002\nB.\u591a\u767c\u6027\u5167\u5206\u6ccc\u816b\u7624\u7b2c\u4e00\u578b (Multiple endocrine neoplasia type 1)\u3002\nC.von Hippel-Lindau\u75c7\u5019\u7fa4 (von Hippel \u2013Lindau disease)\u3002   \nD.\u7d50\u7bc0\u6027\u786c\u5316\u75c7 (Tuberous sclerosis)\u3002\nE.Muir-Torre \u75c7\u5019\u7fa4 (Muir-Torre syndrome)\u3002\n": "[D]", "110-158.62\u6b72\u5973\u6027 3\u5e74\u524d\u958b\u59cb\u5728\u524d\u80f8 \u3001\u4e0a\u80cc (\u5716\u4e00)\u3001\u56db\u80a2\u53ca\u624b\u80cc (\u5716\u4e8c) \u51fa\u73fe\u6414\u7662\u76ae\u75b9 \uff0c\u7121\u53e3\u8154\u9ecf\u819c\u6f70\u760d \uff0c\u6700\u8fd1\u5e7e\u500b\n\u6708\u6709\u4e0b\u80a2\u95dc\u7bc0\u75bc\u75db \uff0c\u722c\u6a13\u68af\u6709\u7121\u529b\u73fe\u8c61 \uff0c\u4e26\u5728\u4e00\u500b\u6708\u524d\u767c\u73fe\u7f79\u60a3\u4e73\u764c \uff0c\u5be6\u9a57\u5ba4\u62bd\u8840\u6aa2\u67e5 \uff1acreatine kinase \n(CK), ALT, AST \u5728\u6b63\u5e38\u7bc4\u570d \uff0cantinuclear antibodies 1:160 (speckled pattern) \u967d\u6027 \uff0canti-Ro/SSA \nantibodies\u9670\u6027 \uff0canti-La/SSB antibodies \u9670\u6027 \u3002\u7d9c\u5408\u4e0a\u8ff0\u6700\u53ef\u80fd\u7684\u8a3a\u65b7\u70ba\u4f55 \uff1f   \nA.\u4e7e\u766c (Psoriasis vulgaris)\u3002\nB.\u76ae\u808c\u708e (Dermatomyositis)\u3002\nC.\u526f\u816b\u7624\u578b\u5929\u75b1\u7621 (Paraneoplastic pemphigus)\u3002\nD.\u4e9e\u6025\u6027\u76ae\u819a\u7d05\u6591\u72fc\u7621 (Subacute cutaneous lupus erythematosus)\u3002\nE.Lambert-Eaton\u808c\u7121\u529b\u75c7\u5019\u7fa4 (Lambert-Eaton myasthenic syndrome)\u3002\n": "[B]", "110-159.26\u6b72\u7537\u6027\u81ea 2\u6b72\u8d77\u8a3a\u65b7\u70ba\u7570\u4f4d\u6027\u76ae\u819a\u708e \uff0c\u671f\u9593\u65b7\u65b7\u7e8c\u7e8c\u63a5\u53d7\u6cbb\u7642 \uff0c\u4e00\u5468\u524d\u6709\u767c\u71d2\u4e26\u958b\u59cb\u7531\u624b\u524d\u81c2\u51fa\u73fe\u6414\u7662\n\u75bc\u75db\u7684\u76ae\u75b9 (\u5716\u4e00)\uff0c\u6709\u63a5\u53d7\u53e3\u670dcephalexin\u6cbb\u7642 \uff0c\u4f46\u76ae\u819a\u75c5\u7076\u5728\u9019\u4e00\u5468\u4ecd\u64f4\u6563\u81f3\u81c9\u90e8 \u3001\u9838\u90e8\u3001\u8ec0\u5e79 (\u5716\n\u4e8c)\u548c\u4e0b\u80a2\uff0c\u8acb\u554f\u4e0b\u5217\u4f55\u8005\u662f\u6700\u6070\u7576\u7684\u8655\u7f6e \uff1f   \nA.Topical mupirocin\u3002\nB.Systemic prednisolone\u3002\nC.Systemic acyclovir\u3002\nD.Intravenous vancomycin\u3002\nE.Oral fluconazole\u3002\n": "[C]", "110-160.\u95dc\u65bc\u9ed1\u8272\u7d20\u7624 (melanoma) \uff0c\u4e0b\u5217\u6558\u8ff0\u4f55\u8005\u6b63\u78ba \uff1f\n(1) \u662f\u76ae\u819a\u764c\u4e2d\u6700\u5e38\u898b\u7684\u985e\u578b\n(2) \u5c31\u7a2e\u65cf\u4e2d\u9ed1\u8272\u7d20\u7624\u7684\u4e9e\u578b\u5206\u5e03\u800c\u8a00 \uff0c\u9ec3\u7a2e\u4eba\u80a2\u7aef\u5c0f\u75e3\u6027\u9ed1\u8272\u7d20\u7624 (acral lentiginous melanoma )\u6240\u5360\u6bd4\n\u4f8b\u6bd4\u767d\u7a2e\u4eba\u591a \uff0c\u767d\u7a2e\u4eba\u9ecf\u819c\u9ed1\u8272\u7d20\u7624 (mucosal melanoma) \u6240\u5360\u6bd4\u4f8b\u6bd4\u9ec3\u7a2e\u4eba\u591a\n(3) \u75e3(nevus)\u662f\u9ed1\u8272\u7d20\u7624\u7684\u5371\u96aa\u56e0\u5b50\u4e4b\u4e00 \uff0c\u7d04\u67097\u6210\u4ee5\u4e0a\u7684\u76ae\u819a\u9ed1\u8272\u7d20\u7624\u662f\u7531\u75e3\u8f49\u8b8a\u800c\u4f86 \u3002\n(4) Breslow\u816b\u7624\u539a\u5ea6\u662f\u9ed1\u8272\u7d20\u7624\u6700\u91cd\u8981\u7684\u9810\u5f8c\u56e0\u5b50\n(5) \u4e00\u4f4d\u7f79\u60a3\u5de6\u8db3\u5e95\u80a2\u7aef\u5c0f\u75e3\u6027\u9ed1\u8272\u7d20\u7624\u768452\u6b72\u5973\u6027 \uff0c\u816b\u7624\u539a\u5ea6\u70ba2 mm\u4f46\u6c92\u6709\u6f70\u760d \uff0c\u5979\u7684\u5de6\u8179\u80a1\u6e9d\u6c92\u6709\u6478\n\u5230\u6dcb\u5df4\u7d50\u816b \uff0c\u4e14\u96fb\u8166\u65b7\u5c64\u6383\u63cf\u6c92\u6709\u770b\u5230\u5168\u8eab\u6027\u8f49\u79fb \uff0c\u6839\u64da\u76ee\u524d\u7684\u6cbb\u7642\u6a19\u6e96 \uff0c\u6b64\u75c5\u60a3\u9664\u4e86\u63a5\u53d7\u76ae\u819a\u816b\u7624\u5ee3\u6cdb\n\u5207\u9664\u5916\u9084\u8981\u65bd\u884c\u524d\u54e8\u6dcb\u5df4\u7d50\u5207\u7247 (sentinel lymph node biopsy )\u3002   \nA.(1)+(2)+(3)+(4)\u3002\nB.(2)+(3)+(4)\u3002\nC.(1)+(3)+(5)\u3002\nD.(4)+(5)\u3002\nE.(3)+(4)+(5)\u3002": "[D]", "111-156.20\u6b72\u7537\u6027\u81ea\u5b69\u7ae5\u671f\u8d77\u8a3a\u65b7\u70ba\u7570\u4f4d\u6027\u76ae\u819a\u708e \uff0c\u671f\u9593\u65b7\u65b7\u7e8c\u7e8c\u63a5\u53d7\u6cbb\u7642 \uff0c\u4e00\u5468\u524d\u6709\u767c\u71d2\u4e26\u5728\u81c9\u9838\u90e8\u51fa\u73fe\u6414\u7662\u75bc\n\u75db\u7684\u76ae\u75b9 (\u5982\u5716)\uff0c\u8acb\u554f\u6700\u53ef\u80fd\u7684\u611f\u67d3\u75c5\u539f\u662f ?   \nA.\u55ae\u7d14\u75b1\u75b9\u75c5\u6bd2 (Herpes simplex virus)\u3002\nB.\u4eba\u985e\u7ec6\u5c0f\u75c5\u6bd2B19 (Human parvovirus B19)\u3002\nC.A\u7fa4\u93c8\u7403\u83cc (Streptococcus, group A)\u3002\nD.\u6c34\u75d8\u5e36\u72c0\u75b1\u75b9\u75c5\u6bd2 (Varicella zoster virus)\u3002\nE.\u91d1\u9ec3\u8272\u8461\u8404\u7403\u83cc (Staphylococcus aureus)\u3002\n": "[A]", "111-157.50\u6b72\u5973\u6027\u6709\u7cd6\u5c3f\u75c5\u53f2 \uff0c4\u5e74\u524d\u56e0\u8179\u75db\u53ca\u6162\u6027\u8179\u7009\u8a3a\u65b7\u70ba\u6f70\u760d\u6027\u7d50\u8178\u708e \uff0c\u4e00\u5468\u524d\u5728\u96d9\u5074\u5c0f\u817f\u7522\u751f\u75bc\u75db\u7684\u76ae\u75b9\n\u53ca\u6f70\u760d\uff0c\u7bc4\u570d\u9010\u6f38\u64f4\u5927 \uff0c\u4e26\u5408\u4f75\u96d9\u4e0b\u80a2\u6c34\u816b (\u5982\u5716)\u3002\u8acb\u554f\u6700\u53ef\u80fd\u7684\u8a3a\u65b7\u70ba\u4f55 \uff1f   \nA.\u52d5\u8108\u6027\u6f70\u760d (Arterial ulcer)\u3002\nB.\u7d50\u7bc0\u6027\u7d05\u6591 (Erythema nodosum)\u3002\nC.\u975c\u8108\u9b31\u6eef\u6027\u6f70\u760d (Venous stasis ulcer)\u3002\nD.\u58de\u75bd\u6027\u81bf\u76ae\u75c7 (Pyoderma gangrenosum)\u3002\nE.\u8102\u80aa\u76ae\u819a\u786c\u5316\u75c7 (Lipodermatosclerosis)\u3002\n": "[D]", "111-158.45\u6b72\u7537\u6027\u5370\u5c3c\u79fb\u5de5 \uff0c\u4e00\u5e74\u524d\u958b\u59cb\u6ce8\u610f\u5230\u81ea\u5df1\u8eab\u9ad4\u51fa\u73fe\u7d05\u8272\u7a81\u8d77\u4e18\u75b9\u53ca\u6591\u584a \uff0c\u75c5\u7076\u9010\u6f38\u64f4\u5c55\u81f3\u81c9\u90e8\u53ca\u56db\n\u80a2\uff0c\u55ae\u4e00\u75c5\u7076\u9762\u7a4d\u4e5f\u8b8a\u5927 \uff0c\u4e00\u500b\u6708\u524d\u767c\u73fe\u5916\u5074\u7709\u6bdb\u812b\u5931 \uff0c\u75c5\u7076\u89f8\u6478\u6642\u6709\u9ebb\u6728\u611f (\u5716\u4e00\u53ca\u5716\u4e8c )\u3002\u76ae\u819a\u5207\u7247\u75c5\n\u7406\u6aa2\u67e5\u53ef\u898b\u76ae\u819a\u771f\u76ae\u5167\u6709\u6ce1\u6cab\u7d30\u80de (foam cells )\u6d78\u6f64\u53ca\u8a31\u591a\u6297\u9178\u6027\u83cc \u3002\u8acb\u554f\u6700\u53ef\u80fd\u7684\u8a3a\u65b7\u70ba\u4f55 \uff1f   \nA.\uf9d0\u7d50\u6838\u578b\u6f22\u751f\u75c5 (Tuberculoid leprosy)\u3002\nB.\u5c0b\u5e38\u72fc\u7621 (Lupus vulgaris)\u3002\nC.\u985e\u8089\u7624\u75c5 (Sarcoidosis)\u3002\nD.\u74b0\u5f62\u8089\u82bd\u816b (Granuloma annulare)\u3002\nE.\u816b\u7624\u578b\u6f22\u751f\u75c5 (Lepromatous leprosy)\u3002\n": "[E]", "111-159.\u5982\u5716\u6240\u793a\u7684\u76ae\u75b9\uff0c\u75c5\u53f2\u5df2\u670910\u5e74\uff0c\u95dc\u65bc\u6b64\u75be\u75c5\u4ee5\u4e0b\u6558\u8ff0\u4f55\u8005\u70ba\u975e\uff1f    \nA.\u6703\u9020\u6210\u95dc\u7bc0\u708e\u53ca\u6307\u7532\u75c5\u8b8a\u3002\nB.\u56e0\u5fc3\u8840\u7ba1\u75be\u75c5\u5c0e\u81f4\u6b7b\u4ea1\u7684\u6bd4\u7387\u6bd4\u4e00\u822c\u4eba\u9ad8\u3002\nC.\u670d\u7528\u03b2\u53d7\u9ad4\u963b\u65b7\u5291\u5982propranolol \u53ef\u80fd\u4f7f\u75be\u75c5\u60e1\u5316\u3002\nD.\u53e3\u670d\u985e\u56fa\u9187\u662f\u7b2c\u4e00\u7dda\u6cbb\u7642\u3002\nE.IL-23\u6291\u5236\u5291\u53caIL-17\u6291\u5236\u5291\u662f\u6709\u6548\u7684\u751f\u7269\u88fd\u5291\u6cbb\u7642\u3002\n": "[D]", "111-160.60\u6b72\u5973\u6027 2\u5e74\u524d\u958b\u59cb\u5728\u524d\u80f8 (\u5716\u4e00)\u3001\u4e0a\u80cc \u3001\u56db\u80a2\u53ca\u624b\u80cc (\u5716\u4e8c) \u51fa\u73fe\u6414\u7662\u76ae\u75b9 \uff0c\u7121\u53e3\u8154\u9ecf\u819c\u6f70\u760d \uff0c\u6700\u8fd1\u5e7e\n\u500b\u6708\u6709\u541e\u56a5\u56f0\u96e3 \uff0c\u722c\u6a13\u68af\u7121\u529b\u7684\u73fe\u8c61 \uff0c\u4e26\u5728\u4e00\u500b\u6708\u524d\u767c\u73fe\u7f79\u60a3\u4e73\u764c \uff0c\u5be6\u9a57\u5ba4\u62bd\u8840\u6aa2\u67e5 \uff1a\u808c\u9178\u6fc0\u9176 \n(creatine kinase )\u5728\u6b63\u5e38\u7bc4\u570d \uff0cantinuclear antibodies 1:160 (speckled pattern) \u967d\u6027 \uff0canti-Ro/SSA \nantibodies\u9670\u6027 \uff0canti-La/SSB antibodies \u9670\u6027 \u3002\u7d9c\u5408\u4e0a\u8ff0\u6700\u53ef\u80fd\u7684\u8a3a\u65b7\u70ba\u4f55 \uff1f   \nA.\u5168\u8eab\u6027\u786c\u5316\u75c7 (Systemic sclerosis)\u3002\nB.\u76ae\u808c\u708e (Dermatomyositis)\u3002\nC.\u4f34\u816b\u7624\u578b\u5929\u76b0\u7621 (Paraneoplastic pemphigus)\u3002   \nD.\u4e9e\u6025\u6027\u76ae\u819a\u7d05\u6591\u6027\u72fc\u7621 (Subacute cutaneous lupus erythematosus)\u3002\nE.\u5305\u6db5\u9ad4\u808c\u708e (Inclusion body myositis)\u3002": "[B]"}